Tag: Pharmaceutical Sector

  • Semaglutide Compounding Dispute: Novo Nordisk Heads To Court

    Danish pharmaceutical giant Novo Nordisk is taking compounding pharmacy iDexis to the Pretoria High Court. The highly anticipated legal battle will take place on June 10. The case focuses on the unauthorised scale production of semaglutide-based weight-loss injections. Novo Nordisk wants the court to stop iDexis from manufacturing, advertising, and distributing these products. The global firm alleges that iDexis is…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in

  • Collaboration with Private Sector to Enhance Healthcare

    In a concerted effort to allay widespread concerns within South Africa’s private healthcare industry, top government officials are actively urging the sector to engage constructively with the proposed National Health Insurance (NHI) framework. Rather than viewing the NHI as a threat, officials are framing it as a transformative national project. This project will create numerous new business and partnership opportunities.…

    Continue reading with a Health Matters subscription

    Subscribers read every article in full, receive the daily briefing and have access to the complete archive.

    SubscribeLog in